Introduction
Chronic pain is a dominating symptom among patients with knee osteoarthritis (OA), and is associated with deteriorating function, e.g. walking disabilities 1 . Pain and function are recommended as core outcome measures in clinical research on OA 2, 3 , and it is crucial that the assessment instruments are valid, discriminative, and sensitive to change in order to determine the effect size of a given treatment 4 . A variety of treatment options exist, but clinical trials show minimal to modest effect sizes 5 , and negative results for treatments previously shown efficacious 6 . These variations may be caused by differences in study populations or methodological biases, e.g. in relation to the underlying constructs of assessment methods. Either way it has put focus on clinical research design and methods, including the need for identification of treatment response indicators 5 .
Quantification of pain and functional disabilities implies methodological challenges, as they are subjective and variable constructs, containing several dimensions. In clinical trials, chronic musculoskeletal pain is commonly assessed retrospectively with unidimensional scales, either with 100 mm visual analogue scales (VAS) or 11, 21 or 101 point numeric rating scales (NRS), i.e. from 0-10, 0-20 or 0-100, anchored at the extremes with verbal descriptors (e.g. 0 = "no pain", 100 = "worst pain imaginable") 7 . VAS and NRS are found to be valid measures of pain intensity in a variety of populations 8 , yet critics raise questions of the psychometric properties of single item measures 9, 10 . In knee OA, pain and function are commonly assessed with patient-reported multidimensional questionnaires, e.g. the Knee injury and Osteoarthritis Outcome Score (KOOS) 11 . The KOOS has shown good psychometric qualities, i.e. sensitivity to change, construct validity (with SF-36), and reliability of the KOOS questionnaire and VAS scores during walking.
Pain scoring
As part of the CAROT study the patients underwent a biomechanical gait analysis. The full gait analysis protocol and results are given elsewhere 24 . In brief, the patients walked a 10 m walkway 15-20 times at a self-selected comfortable walking speed. After completion of the gait analyses, the patients were asked to rate their target knee pain during the gait analyses on a 100 mm VAS ("Please indicate your pain intensity while walking, on this line going from no pain to worst pain imaginable"), with the extremes anchored; 0 = "no pain" and 100 = "worst pain imaginable". This score is referred to as VASwalking. The data were collected by an experienced PhD-student, who was blinded to the KOOS data.
Before the gait analysis and walking pain ratings, the KOOS 11 were filled in by the patients, related to their target knee. KOOS consists of 42 items distributed on five subscales; Pain, other Symptoms, Function in daily living, Function in sport and recreation, and knee-related Quality of life. Items relate to experiences during the last week. Standardised response options are given on five-point Likert scales, and each item response equals a score from 0 to 4 (none = 0, mild = 1, moderate = 2, severe = 3, extreme = 4). A normalised score from 0 to 100 is calculated for each subscale (100 = no symptoms and 0 = extreme symptoms). In the present study, the KOOS pain subscale and item 5 in the KOOS pain subscale, KOOSp05 ("What amount of knee pain have you experienced the last week during walking on flat surface?") were extracted for analyses.
Statistical analysis
The agreement between VASwalking and the KOOSp05 item was illustrated by a diagram showing the has showed sensitivity to change as demonstrated in a proof-of-concept walking model 20 and in a recent clinical study 21 . The authors state that the standardisation of current pain, i.e. evoking pain with a pain provoking function, yields a more direct and unbiased response. However, walking models as assessment instruments have not been tested against a validated measurement instrument. Our objective was to explore whether pain measured with KOOS differs from pain during walking measured with a single item 0-100 mm VAS after a walking task.
Materials and methods
Data from knee OA patients included in the dietary intervention study, "The Influence of Weight loss or Exercise on Cartilage in Obese Knee OA Patients (The CAROT Trial)" 22 , were used in the current study. Eligibility criteria for the CAROT participants were: Obese, having a body-mass index (BMI) of more than 30 kg/m 2 ; more than 50 years of age, primary knee OA diagnosed according to the American College of Rheumatology criteria 23 ; clinical symptoms and radiographically or arthroscopically verified osteoarthritis in one or both knees; and ability to walk independently (without walking aid). The CAROT study was designed with an initial weight loss intervention period of 16 weeks, after which a maintenance period of additional 52 weeks was commenced. At inclusion into the CAROT study, the patients' more symptomatic knee was determined and designated as the target knee throughout the study. If both knees were involved, the more symptomatic knee was chosen based on patient reports. The CAROT study was approved by the local ethical committee (ID: H-B-2007-088). The present study presents cross-sectional data recorded after the initial 16 weeks weight loss intervention. Eligibility criteria for inclusion to this particular study were complete recordings in clinical trials. Yet KOOS faces uncertainties and there are no reported values for internal consistency or floor and ceiling effects in patients with knee OA 12 . Further, lengthy multidimensional questionnaires are prone to random answers due to irrelevance 13 , and retrospectivity introduces the risk of recall bias 14, 15 . Some observations indicate that recalling pain tends to provide overestimation of pain intensity, as a study concludes that the best estimate of true average pain is the arithmetic average between recalled least pain and recalled average pain 9 . Further, it is shown that current pain intensity influences pain ratings [16] [17] [18] which increases the risk of recall bias. Another problem with questionnaires, both multi-and unidimensional, is the phenomenon response shift, i.e. responders changing reference points (e.g. a healthy/more disabled self or peer) in evaluating their pain or function, showing no temporal or contextual consistency 13 . Finally, the KOOS was developed to use in clinical trials and the applicability for clinical practice is limited. In some clinical settings it may not be custom to use measurement instruments at all, or very limited. If clinicians are to use measurement instruments, it is crucial that the interpretation is clear, which demands a distinct identification of the underlying construct.
In the attempt to circumvent these limitations, researchers have used walking models to mimic characteristic knee OA pain while measuring pain, in order to avoid recall bias and limit response shift. In knee OA patients, walking constitutes a clinically relevant pain provoking function, and at the same time a function impaired due to pain. The measure therefore reflects both pain in function and functional limitations due to pain, a concept supported by the notion that pain and function can be regarded as two aspects of the same construct , where the time weighted average pain intensity, rated on an 11-point NRS during walking was compared to ratings on the Western Ontario McMaster Universities Osteoarthritis Index displaying the VASwalking median within each category. On a group level, participants who rated their pain as mild (category 2) and moderate (category 3) in the questionnaire display uniform VAS pain ratings with medians of 10 (range 0-55) and 11 (range 0-60), respectively. It should be noted that no participants rated their pain as extreme (category 4), and only three rated their pain as severe (category 3). The VASwalking and KOOSp05 were positively associated, assessed by the Spearman correlation coefficient; r = 0.51; p < 0.0001.
The relation between the reversed KOOSpain scores and the VASwalking scores is presented in Figure 2 , with line of equality. Mean VASwalking score was 11.1 mm (SD 13.3 mm), and mean KOOSpain score was 70.0 (SD 18.6), making the mean reversed KOOSpain score 30.0 (KOOSrev). Means are presented in Table 1 . Mean difference between VASwalking and KOOSpain scores was 18.8 (SD 16.6, 95% confidence interval 16.1 to 21.6), and the Limits of Agreement (mean + 1.96SD) were -13.6 and 51.3, as illustrated in Figure 3 . distribution of VASwalking scores within the five response categories of the KOOSp05 item. To assess, any association of Spearman correlation coefficients between VASwalking and KOOSp05 was calculated. The agreement between the KOOS pain subscale and VASwalking were estimated with the Limits of Agreement method described by Bland and Altman 25 . To ease the interpretability of the results, the normalised KOOS pain subscale score was reversed to the same polarity as the VAS score (i.e. 0 = no pain and 100 = extreme pain).
Results
Complete recordings of pain from both VASwalking and KOOS questionnaire at the 16 week follow-up session were available from 143 patients. Demographic and baseline characteristics are presented in Table 1 , showing no differences between the entire CAROT cohort and the sub-cohort of participants included in this study.
The distribution of VASwalking scores within KOOSp05 response categories is seen in Figure 1 , also . Rating pain subsequent to a walking test as presented in this study is not a standardised assessment method, and for that reason alone, comparing it against a validated questionnaire as KOOS implies interpretational limitations. Several parameters potentially influence the process of rating subjective variables as pain and function, e.g. the setting (sitting down filling out the questionnaire versus standing/ sitting in a gait laboratory shortly after a walking task), the visual presentation (rating 42 items on a 5 point Likert scale in a four-page questionnaire versus marking a point on a 100 mm straight line with the anchors "no pain" and "worst pain imaginable"), and length of required retrospectivity (up to one week versus few minutes). These parameters are likely to determine the responses to some degree, as they influence which associations the participants get when presented with the items, e.g. do the responders relate to the content, are they distracted when answering, are they influenced by presence of a researcher, do they remember their walking pain/difficulties specifically or a more overall pain/disability experience? Thus, methodological biases cannot be ruled out in this study, yet the possibility of different constructs measured as an explanation of the divergent results must also be considered.
The multidimensionality of pain, containing both the sensory intensity of pain and the emotional pain perception 26 , is reflected in the different modalities of pain treatment, i.e. pharmacological and physical versus psychosocial and behavioural treatment modalities 27 . Self report (P = 0.01) for WOMAC pain subscale, and r = 0.2 (P = 0.08) for WOMAC physical function subscale 21 . Whether these divergences between questionnaires and walking models reflect methodological conditions or that separate constructs (WOMAC), which is included in the KOOS questionnaire. Correlation coefficients between the two outcomes were low; r = 0.4 for WOMAC item, "What amount of knee pain have you experienced the last 48 hours during walking on flat surface?", r = 0.2 constructs are measured by existing OA pain assessment methods, compromising the interpretation of results to determine treatment effects. As different treatment modalities target different components of the pain experience, the assessment methods should reflect constructs of the corresponding pain components in order to fulfil their role as response indicators. Currently, this does not seem to be the case. The generally modest effect sizes seen in chronic pain treatment trials (5;6) and OA clinical trials 37 where patient reported outcomes are standard, cause researchers to state that there is "a crucial need for identification of indicators of treatment response" 5 . A possible lack of construct validity of commonly used assessment methods might be a part of the problem.
It is shown that patients incorporate various factors when rating pain, e.g. impact on activities, level of distress, and comparison with "worst" and "usual" pain, but not consistently the same way, i.e. response shift 10 . Experiencing pain and functional limitations simultaneously with pain rating may help focus on the knee pain and to a certain extent omit other factors contributing to the pain experience, as concluded in a recent study 21 . A possible consequence of this could be a shift in the construct measured as well, i.e. while the KOOS pain experience is a broad psychosocial and contextual construct, the walking-related pain experience might be a primarily sensory construct, dominated by the physiological pain perception. Supportive to this assumption, the walking model with NRS pain intensity scoring by Peeva et al. 21 showed sensitivity to change with relatively large effect sizes of 0.9-1.2, thus suggesting that OA knee pain can be adequately measured during walking, possibly reflecting a construct that is closer related to the target of pharmacological and training interventions, than the constructs captured with conventional questionnaires.
to reflect sensory rather than emotional pain dimensions in a study on women with chronic musculoskeletal pain 32 . The weighting of the sensory and emotional aspects of pain in OA pain reports is unknown, though it has been shown that depression and anxiety associated with chronic pain (1;33), yield higher pain scores on unidimensional scales 34 , indicating that the emotional proportion of the pain experience increases with affective suffering. In accordance, it has been suggested that chronic pain patients have an information processing bias towards affective pain descriptors 35 , and that chronic pain can lead to a lack of dissociation between the affective and sensory components of pain 36 . Thus, uncertainty remains about the sensory and emotional contributions to pain experience in knee OA and thereby which questionnaires assess pain experience, a construct influenced by numerous known and unknown factors, physiological as well as psychosocial and contextual [28] [29] [30] , i.e. embracing both the sensory and emotional components of pain. The extent to which each of these factors contributes to the pain experience is individual and variable, thus preventing a precise description of the target construct of the assessment, which is disturbing for the sensitivity of the measurement instrument and the interpretation of the results 10 . Analysis of construct validity conclude that scores on unidimensional numerical pain intensity rating scales reflect the emotional qualities of pain much more than its sensory intensity in post-operative 9 , and chronic 31 cancer patients. In contrast, pain intensity scales (NRS and VAS) seems 
